XML 89 R77.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidating Financial Information - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash Flow from Operating Activities:    
Net cash provided by operating activities $ 99,011 $ 69,686
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 2,503 4,504
Proceeds from sale of property and equipment 274 0
Proceeds from sale of assets held for sale 0 3,797
Change in restricted investments (4,062) (505)
Capital expenditures (28,084) (52,147)
Net cash used in investing activities (29,369) (44,351)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 130,000 102,000
Payments on long-term debt (96,926) (43,000)
Payments on non-recourse debt (2,089) (5,600)
Taxes paid related to net share settlements of equity awards (4,172) (4,356)
Payment for repurchases of common stock 0 (40,182)
Proceeds from issuance of common stock in connection with ESPP 124 140
Debt issuance costs   (40,182)
Proceeds from the exercise of stock options 333 260
Dividends paid (57,945) (58,238)
Net cash used in financing activities (30,675) (48,976)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 366 (655)
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 39,333 (24,296)
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 84,472 133,545
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 123,805 109,249
The GEO Group, Inc.    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 14,354 39,888
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 0 0
Proceeds from sale of property and equipment 0  
Proceeds from sale of assets held for sale   0
Change in restricted investments 0 0
Capital expenditures (6,608) (34,360)
Net cash used in investing activities (6,608) (34,360)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 130,000 102,000
Payments on long-term debt (96,926) (43,000)
Payments on non-recourse debt 0 0
Taxes paid related to net share settlements of equity awards (4,172) (4,356)
Proceeds from issuance of common stock in connection with ESPP 124 140
Debt issuance costs   (40,182)
Proceeds from the exercise of stock options 333 260
Dividends paid (57,945) (58,238)
Net cash used in financing activities (28,586) (43,376)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 0 0
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (20,840) (37,848)
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 54,666 54,666
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 33,826 16,818
Combined Subsidiary Guarantors    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 20,879 17,614
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 2,503 4,504
Proceeds from sale of property and equipment 274  
Proceeds from sale of assets held for sale   3,797
Change in restricted investments (4,062) (505)
Capital expenditures (21,452) (16,654)
Net cash used in investing activities (22,737) (8,858)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt 0 0
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 0 0
Debt issuance costs   0
Proceeds from the exercise of stock options 0 0
Dividends paid 0 0
Net cash used in financing activities 0 0
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 0 0
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (1,858) 8,756
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 4,823 4,952
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 2,965 13,708
Combined Non-Guarantor Subsidiaries    
Cash Flow from Operating Activities:    
Net cash provided by operating activities 63,778 12,184
Cash Flow from Investing Activities:    
Insurance proceeds - damaged property 0 0
Proceeds from sale of property and equipment 0  
Proceeds from sale of assets held for sale  
Change in restricted investments 0 0
Capital expenditures (24) (1,133)
Net cash used in investing activities (24) (1,133)
Cash Flow from Financing Activities:    
Proceeds from long-term debt 0 0
Payments on long-term debt 0 0
Payments on non-recourse debt (2,089) (5,600)
Taxes paid related to net share settlements of equity awards 0 0
Proceeds from issuance of common stock in connection with ESPP 0 0
Debt issuance costs   0
Proceeds from the exercise of stock options 0 0
Dividends paid 0 0
Net cash used in financing activities (2,089) (5,600)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 366 (655)
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents 62,031 4,796
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 24,983 73,927
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period $ 87,014 $ 78,723